Affordability and drug pricing
High out-of-pocket costs remain a top concern for patients. Policy options on the table include broader price negotiation for prescription drugs, targeted caps on insulin and other essential medicines, and reforms to how rebates are handled in the commercial insurance market.
States and federal regulators are experimenting with programs meant to lower list prices and increase competition, such as importing drugs under strict safety standards and supporting biosimilar uptake. Employers and pharmacy benefit managers also play a central role: changes to benefit design and cost-sharing can provide immediate relief while longer-term policy shifts aim to address root causes of price inflation.
Access and coverage dynamics
Expanding insurance coverage still centers on Medicaid policy, marketplace stability, and employer-sponsored plans. Several states have moved to expand Medicaid eligibility or to streamline enrollment, reducing churn and improving continuity of care. At the same time, efforts to shore up marketplace affordability—through enhanced subsidies or state-based premium supports—remain focal points for keeping coverage accessible for people without employer plans.
Nonfinancial barriers such as transportation, language access, and immigration-related fear also shape who actually receives care, prompting targeted outreach and community-based solutions.
Delivery system transformation
The shift from fee-for-service to value-based payment models continues to accelerate. Accountable care arrangements, bundled payments, and risk-sharing contracts aim to align incentives toward prevention and care coordination. Hospitals and health systems are increasingly measured on outcomes, patient experience, and cost efficiency, pushing investments into care management, social determinants screening, and population health analytics.
Telehealth has transitioned from an emergency workaround to a mainstream access tool. Policy priorities include permanent reimbursement rules that reflect the value of virtual care, licensure reforms to enable cross-state practice, and stronger guidance on quality and equity in digital health.
Interoperability and data sharing are crucial enablers for coordinated care; regulators and the private sector are under pressure to make health data portable, secure, and useful at the point of care.
Workforce and rural health
Workforce shortages—especially in primary care, behavioral health, and rural hospitals—affect access and drive higher costs through avoidable emergency care. Policy responses include loan repayment incentives, expanded scopes of practice for nurse practitioners and physician assistants, and targeted funding to sustain rural hospitals and community clinics. Telehealth and mobile clinics help bridge gaps, but physical workforce investments remain essential for long-term resilience.
Transparency, competition, and consumer protections
Price transparency and protections against surprise billing have empowered consumers, but implementation challenges persist. Antitrust scrutiny of hospital mergers and pharmacy benefit chains seeks to address consolidation-driven price increases. Consumer advocates are also pushing for clearer billing practices and easier comparison tools so patients can make informed choices.
What to watch
Key developments to monitor include regulatory changes affecting telehealth reimbursement and licensure, state actions on drug price interventions, the expansion of value-based payment models, and measures aimed at strengthening the healthcare workforce. For stakeholders, the most effective strategies combine policy engagement with operational reforms: improving care coordination, investing in technology that supports interoperability, and designing benefits that reduce financial barriers for patients.
Policy shifts will keep reshaping incentives across the system. Organizations that align care delivery, cost management, and patient-centered design will be best positioned to adapt and to deliver better outcomes while containing spending pressures.